×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
|
Dashboard
Analyses
Exchange
Gaps
←
Home
/
Wiki
/
Clinical: A 6-month & 18-month Prospective, Randomized, Placebo-contro
clinical
1,170 words
KG: A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
Contents
A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Related Hypotheses (26)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.77
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Epigenetic Memory Erasure via TET2 Activation
Score: 0.74
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.72
Noradrenergic-Tau Propagation Blockade
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai
Score: 0.67
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.67
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66
Temporal TET2-Mediated Hydroxymethylation Cycling
Score: 0.66
Arginine Methylation Enhancement Therapy
Score: 0.65
KDM6A-Mediated H3K27me3 Rejuvenation
Score: 0.65
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.65
Synaptic Vesicle Tau Capture Inhibition
Score: 0.55
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.55
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
Show 21 more
Related Analyses (3)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Related Experiments (1)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
See Also (15)
Section 194: Advanced Mitochondrial Dynamics and Biogen
therapeutic · Pages share 5 hypotheses
Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 5 hypotheses
A Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 5 hypotheses
Mitochondrial Replacement Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Mitochondrial Biogenesis Inducers in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Neurodegeneration
disease · Pages share 5 hypotheses
Optogenetically-Modified Neurons in Neurodegeneration R
cell · Pages share 5 hypotheses
p-Tau Biomarker in Immunoglobulin Light Chain and Trans
biomarker · Pages share 4 hypotheses
Neuroimaging Biomarkers for Neurodegeneration
biomarker · Pages share 4 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 4 hypotheses
Exosomal miR-155 in Neurodegeneration
biomarker · Pages share 4 hypotheses
Glutamate - Excitotoxicity and Neurodegeneration Biomar
biomarker · Pages share 4 hypotheses
IL-6 (Interleukin-6) in Neurodegeneration
biomarker · Pages share 4 hypotheses
Liquid Biopsy in Neurodegeneration
biomarker · Pages share 4 hypotheses
Exosomal Biomarkers in Neurodegeneration
biomarker · Pages share 4 hypotheses
Show 10 more
Knowledge Graph (1 edges)
A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
references
BACE1
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)